Emcure Pharmaceuticals, a company in the Pharmaceuticals industry, reported revenue of ₹2,820 crore and net profit of ₹325 crore for the September 2026 quarter.
Emcure Pharmaceuticals (NSE: EMCURE) closed at ₹2,337.80 on 20 Nov 2026, up 71.7% over the past year. Its market capitalisation is ₹44,351 crore and it trades at 39.9 times earnings.
Incorporated in 1981, Emcure Pharmaceuticals Ltd manufactures and markets pharmaceutical products globally
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.